Plasma amyloid, tau, and neurodegeneration biomarker profiles predict Alzheimer's disease pathology and clinical progression in older adults without dementia

INTRODUCTION: Plasma markers have been reported to be associated with brain amyloid burden, tau pathology, or neurodegeneration. We aimed to evaluate whether plasma biomarker profiles could predict Alzheimer's disease (AD) pathology and clinical progression in older adults without dementia. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Xue‐Ning, Li, Jie‐Qiong, Wang, Hui‐Fu, Li, Hong‐Qi, Huang, Yu‐Yuan, Yang, Yu‐Xiang, Tan, Lan, Dong, Qiang, Yu, Jin‐Tai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Blood‐based Biomarkers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7513626/
https://www.ncbi.nlm.nih.gov/pubmed/33005724
http://dx.doi.org/10.1002/dad2.12104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7513626/
https://www.ncbi.nlm.nih.gov/pubmed/33005724
http://dx.doi.org/10.1002/dad2.12104

Ejemplares similares